Loading insider details...
Beta
Latest Form 4 (Sep 4, 2026): Grant/Award of 62,800 ATNM shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 4, 2026 | Actinium Pharmaceuticals, Inc. (ATNM) | Grant/Award | 62,800 | n/a |
| Jun 18, 2026 | BioXcel Therapeutics, Inc. (BTAI) | Exercise/Conversion | 35 | n/a |
| May 22, 2026 | BioXcel Therapeutics, Inc. (BTAI) | Exercise/Conversion | 17,500 | n/a |
| May 14, 2026 | ATOSSA THERAPEUTICS, INC. (ATOS) | Grant/Award | 10,000 | n/a |
| May 7, 2026 | BioXcel Therapeutics, Inc. (BTAI) | Exercise/Conversion | 9,000 | n/a |
| Mar 17, 2026 | BioXcel Therapeutics, Inc. (BTAI) | Exercise/Conversion | 33 | n/a |
| Jan 6, 2026 | BioXcel Therapeutics, Inc. (BTAI) | Grant/Award | 70,000 | n/a |
| Dec 16, 2025 | BioXcel Therapeutics, Inc. (BTAI) | Exercise/Conversion | 33 | n/a |
| Sep 16, 2025 | BioXcel Therapeutics, Inc. (BTAI) | Exercise/Conversion | 33 | n/a |
| Aug 6, 2025 | BioXcel Therapeutics, Inc. (BTAI) | Grant/Award | 9,000 | n/a |